Cargando…
A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries
Myocardial infarction (MI) is a significant cause of morbidity and mortality in low- and middle-income countries. Fibrinolytic agents and percutaneous coronary intervention (PCI) are the main approaches for the recanalization and reperfusion of the myocardium following MI. Many studies have shown th...
Autores principales: | Muoghalu, Chioma G, Ekong, Ndianabasi, Wyns, William, Ofoegbu, Cosmas C, Newell, Micheal, Ebirim, Danvictor A, Alex-Ojei, Sandra T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518219/ https://www.ncbi.nlm.nih.gov/pubmed/37750155 http://dx.doi.org/10.7759/cureus.44125 |
Ejemplares similares
-
Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis
por: Kathirvel, D., et al.
Publicado: (2018) -
Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital
por: Bawaskar, Himmatrao S., et al.
Publicado: (2019) -
A Complicated Case of COVID-19-Induced Inferolateral Wall Myocardial Infarction Successfully Treated With Streptokinase
por: Hussain, Taimoor, et al.
Publicado: (2021) -
Factors Associated With Normal Flow (TIMI 3) After Thrombolysis With Streptokinase in ST-Elevation Myocardial Infarction: A Prospective Observational Study
por: Raghuram, Karthik, et al.
Publicado: (2021) -
Tenecteplase compared with streptokinase and heparin in the treatment of pulmonary embolism: an observational study
por: Agrawal, Ashish, et al.
Publicado: (2017)